NasdaqGM:AXSMPharmaceuticals
Is It Time To Reassess Axsome Therapeutics (AXSM) After A 75% One Year Surge?
Wondering if Axsome Therapeutics at around US$185.96 is offering fair value or stretching expectations? This breakdown will help you frame what the current price might be implying.
The stock has seen a 14.9% return over the last 30 days and a 75.0% return over the last year. The year to date return sits at 4.1%, while the 7 day return is a 1.6% decline.
Recent headlines around Axsome have focused on the company as a higher profile name within pharmaceuticals and biotech. This helps explain...